CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients

CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients

Background The CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) is a key regulator of the programed death receptor ligand-1 (PD-L1) protein. However, the usefulness of CMTM6 expression as a prognostic indicator and the relationship between CMTM6 and PD-L1 expression in gastric cancer (GC)...

Full description

Bibliographic Details
Main Authors:	Xin Li, Ling Chen, Chuan Gu, Qiaoli Sun, Jia Li
Format:	Article
Language:	English
Published:	PeerJ Inc. 2020-08-01
Series:	PeerJ
Subjects:	CMTM6 PD-L1 Gastric cancer Prognosis
Online Access:	https://peerj.com/articles/9536.pdf

Similar Items

Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
by: Chao Zhang, et al.
Published: (2021-01-01)

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
by: Hiroto Takeuchi, et al.
Published: (2020-06-01)

Expression and clinical significance of CMTM1 in hepatocellular carcinoma
by: Song Xin, et al.
Published: (2021-01-01)

Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients
by: Young Wha Koh, et al.
Published: (2019-10-01)

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
by: Sandra Martinez-Morilla, et al.
Published: (2021-01-01)

Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment
by: Yanbin Zhao, et al.
Published: (2021-01-01)

Down-Regulated CMTM2 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
by: Zhang S, et al.
Published: (2020-06-01)

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
by: Xiaoting Huang, et al.
Published: (2021-03-01)

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
by: Malina Xiao, et al.
Published: (2021-03-01)

Overexpression of CMTM7 inhibits cell growth and migration in liver cancer
by: Zi‐Ming Huang, et al.
Published: (2019-06-01)

Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances
by: Zhi Chen, et al.
Published: (2021-01-01)

MicroRNA-205 inhibits renal cells apoptosis via targeting CMTM4
by: Hongxia Zhang, et al.
Published: (2015-10-01)

CMTM family proteins 1–8: roles in cancer biological processes and potential clinical value
by: Jie Wu, et al.
Published: (2020-08-01)

CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
by: Wanqiong Yuan, et al.
Published: (2021-09-01)

Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients
by: Yusuke Kono, et al.
Published: (2020-03-01)

CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling
by: Gang Xu, et al.
Published: (2017-11-01)

Interaction of the CMTM7 rs347134 Polymorphism with Dietary Patterns and the Risk of Obesity in Han Chinese Male Children
by: Qi Zhu, et al.
Published: (2020-02-01)

CMTM3 suppresses bone formation and osteogenic differentiation of mesenchymal stem cells through inhibiting Erk1/2 and RUNX2 pathways
by: Dongwei Fan, et al.
Published: (2021-11-01)

Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer
by: Jianmin Zeng, et al.
Published: (2021-07-01)

CMTM7 as a novel molecule of ATG14L-Beclin1-VPS34 complex enhances autophagy by Rab5 to regulate tumorigenicity
by: Baocai Liu, et al.
Published: (2021-07-01)

High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer
by: Zongxian Zhao, et al.
Published: (2021-09-01)

miR-149-5p Regulates Goat Hair Follicle Stem Cell Proliferation and Apoptosis by Targeting the CMTM3/AR Axis During Superior-Quality Brush Hair Formation
by: Jian Wang, et al.
Published: (2020-11-01)

Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients
by: Xiaofang Xing, et al.
Published: (2018-03-01)

Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis
by: Chong Lu, et al.
Published: (2021-07-01)

G6PD-NF-κB-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2
by: Bin Chen, et al.
Published: (2021-02-01)

Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer
by: Jing Chen, et al.
Published: (2021-07-01)

Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer
by: Guo Y, et al.
Published: (2017-07-01)

TRIP6 functions as a potential oncogene and facilitated proliferation and metastasis of gastric cancer
by: Zhu L, et al.
Published: (2019-06-01)

Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression
by: M. Pötzsch, et al.
Published: (2020-01-01)

The N6-Methyladenosine Features of mRNA and Aberrant Expression of m6A Modified Genes in Gastric Cancer and Their Potential Impact on the Risk and Prognosis
by: Liang Sang, et al.
Published: (2020-11-01)

LINC00242/miR-1-3p/G6PD axis regulates Warburg effect and affects gastric cancer proliferation and apoptosis
by: Peng Deng, et al.
Published: (2021-01-01)

Prognostic Role of PD-1 and PD-L1 Expression in Gastric Cancer Patients: A Meta-analysis
by: WANG Yufeng, et al.
Published: (2020-05-01)

M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer
by: Rui Zhao, et al.
Published: (2021-01-01)

Molecular characterization of G6PD mutations reveals the high frequency of G6PD Aures in the Lao Theung population
by: Amkha Sanephonasa, et al.
Published: (2021-01-01)

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
by: Silvio Däster, et al.
Published: (2020-04-01)

CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies
by: Min Fang, et al.
Published: (2016-11-01)

Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer
by: Huifang Lv, et al.
Published: (2021-02-01)

Corrigendum: Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer
by: Huifang Lv, et al.
Published: (2021-04-01)

EGLIF-CAR-T Cells Secreting PD-1 Blocking Antibodies Significantly Mediate the Elimination of Gastric Cancer
by: Zhou JT, et al.
Published: (2020-09-01)

EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
by: Wenjing Gong, et al.
Published: (2021-04-01)